Thromb Haemost 1983; 50(02): 552-556
DOI: 10.1055/s-0038-1665253
Original Article
Schattauer GmbH Stuttgart

T-Cell Alterations in Hemophiliacs Treated with Commercial Clotting Factor Concentrates

K Lechner
The Division of Hematology and Blood Coagulation, First Department of Medicine; Institute of Immunology; Institute of Blood Group Serology; Department of Dermatology and Department of Pediatrics, University of Vienna, Austria
,
H Niessner
The Division of Hematology and Blood Coagulation, First Department of Medicine; Institute of Immunology; Institute of Blood Group Serology; Department of Dermatology and Department of Pediatrics, University of Vienna, Austria
,
P Bettelheim
The Division of Hematology and Blood Coagulation, First Department of Medicine; Institute of Immunology; Institute of Blood Group Serology; Department of Dermatology and Department of Pediatrics, University of Vienna, Austria
,
E Deutsch
The Division of Hematology and Blood Coagulation, First Department of Medicine; Institute of Immunology; Institute of Blood Group Serology; Department of Dermatology and Department of Pediatrics, University of Vienna, Austria
,
I Fasching
The Division of Hematology and Blood Coagulation, First Department of Medicine; Institute of Immunology; Institute of Blood Group Serology; Department of Dermatology and Department of Pediatrics, University of Vienna, Austria
,
M Fuhrmann
The Division of Hematology and Blood Coagulation, First Department of Medicine; Institute of Immunology; Institute of Blood Group Serology; Department of Dermatology and Department of Pediatrics, University of Vienna, Austria
,
W Hinterberger
The Division of Hematology and Blood Coagulation, First Department of Medicine; Institute of Immunology; Institute of Blood Group Serology; Department of Dermatology and Department of Pediatrics, University of Vienna, Austria
,
C Korninger
The Division of Hematology and Blood Coagulation, First Department of Medicine; Institute of Immunology; Institute of Blood Group Serology; Department of Dermatology and Department of Pediatrics, University of Vienna, Austria
,
E Neumann
The Division of Hematology and Blood Coagulation, First Department of Medicine; Institute of Immunology; Institute of Blood Group Serology; Department of Dermatology and Department of Pediatrics, University of Vienna, Austria
,
K Liszka
The Division of Hematology and Blood Coagulation, First Department of Medicine; Institute of Immunology; Institute of Blood Group Serology; Department of Dermatology and Department of Pediatrics, University of Vienna, Austria
,
W Knapp
The Division of Hematology and Blood Coagulation, First Department of Medicine; Institute of Immunology; Institute of Blood Group Serology; Department of Dermatology and Department of Pediatrics, University of Vienna, Austria
,
W R Mayr
The Division of Hematology and Blood Coagulation, First Department of Medicine; Institute of Immunology; Institute of Blood Group Serology; Department of Dermatology and Department of Pediatrics, University of Vienna, Austria
,
G Stingl
The Division of Hematology and Blood Coagulation, First Department of Medicine; Institute of Immunology; Institute of Blood Group Serology; Department of Dermatology and Department of Pediatrics, University of Vienna, Austria
,
U Zeitlhuber
The Division of Hematology and Blood Coagulation, First Department of Medicine; Institute of Immunology; Institute of Blood Group Serology; Department of Dermatology and Department of Pediatrics, University of Vienna, Austria
› Author Affiliations
Further Information

Publication History

Received 25 April 1983

Accepted 01 June 1983

Publication Date:
18 July 2018 (online)

Summary

Various immunological parameters were determined in 46 patients with severe hemophilia A and in 9 patients with severe hemophilia B. All patients were treated over many years with commercial factor VIII or IX concentrates. Patients with severe classic hemophilia had a significantly reduced relative and absolute number of T-helper cells and a significantly increased relative and absolute number of T-suppressor cells. About half of these patients had an inverse T-helper/suppressor cell ratio. Patients with moderate hemophilia A and severe hemophilia B did not show these abnormalities. Hemophiliacs with an inverse ratio had a significantly higher concentration of serum total protein, IgG and IgM. No relationship between the amount of factor VIII concentrate administered, the HLA-type of the patient, the presence or absence of CMV-antibodies, hepatitis markers, thrombocytopenia and abnormal liver function tests to the T-cell abnormalities could be established. Lymphadenopathy was frequently associated with an inverse ratio. Indirect evidence suggests that the alterations of the immune system began in 1979/80.

 
  • References

  • 1 Ikkala E, Helske T, Myllylä G, Nevanlinna HR, Pitkänen P, Rasi V. Changes in the life expectancy of patients with severe haemophilia A in Finland in 1930-79. Br J Haematol 1982; 52: 7-12
  • 2 Enck RE, Betts RF, Brown MR, Miller G. Viral serology (hepatitis B virus, cytomegalovirus, Epstein-Barr virus) and abnormal liver function tests in transfused patients with hereditary hemorrhagic disease. Transfusion 1979; 19: 32-38
  • 3 Hruby MA, Schauf V. Transfusion-related short incubation hepatitis in hemophilic patients. J Am Med Assoc 1978; 240: 1355-1357
  • 4 Schimpf KL, Zimmermann K, Rudel J, Thanner G, Zeltsch P. Result of liver biopsies, rate of icteric hepatitis and frequency of anti-Hbs and Hbs-antigen in patients of the Heidelberg hemophilia centre. Thromb Haemostas 1977; 38: 340 (Abstr)
  • 5 Spero JA, Lewis JH, David H. et al. Asymptomatic structural liver disease in haemophilia. N Engl J Med 1978; 298: 1373-1378
  • 6 Gottlieb MS, Schroff R, Schanker HM. et al. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of an acquired cellular immunodeficiency. N Engl J Med 1982; 305: 425-431
  • 7 Masur H, Michelis MA, Greene JB. et al. An outbreak of community- acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction. N Engl J Med 1981; 305: 1431-1438
  • 8 Midvan D, Mathur U, Enlow RW. et al. Opportunistic infections and immune deficiency in homosexual men. Ann Intern Med 1982; 96: 700-704
  • 9 Siegal FP, Lopez C, Hammer GS. et al. Severe acquired immunodeficiency in male homosexuals, manifested by chronic perianal ulcerative herpes simplex lesions. N Engl J Med 1981; 305: 1439-1444
  • 10 Eyster ME, Koch KL, Abt AB, Shankey TV. Cryptosporidiosis in a hemophiliac with acquired immunodeficiency. Blood 1982; 60 Suppl (Suppl. 01) 211 a (Abstr)
  • 11 Pneumocystis carinii pneumonia among persons with hemophilia A. Morbid Mortal Weekly Rep. 1982 31. 365-367
  • 12 Ragni MV, Lewis JH, Spero JA, Bontempo FA. Acquired immundeficiency-like syndrome in two hemophiliacs. Lancet 1983; 1: 213-214
  • 13 Jones P, Proctor S, Dickinson A, George S. Altered immunology in hemophilia. Lancet 1983; 1: 120
  • 14 Ledermann MM, Ratnoff OD, Scillian JJ, Jones PK, Schachter B. Impaired cell-mediated immunity in patients with classic hemophilia. N Engl J Med 1983; 308: 79-83
  • 15 Luban NL C, Kelleher JF. Altered distribution of T-lymphocyte subpopulations in children and adolescents with haemophilia. Lancet 1983; 1: 503
  • 16 Luban NL C, Kelleher JF, Reaman GH. Investigation of immune status in children and adolescents with hemophilia. Blood 1982; 60 Suppl (Suppl. 01) 216 a (Abstr)
  • 17 Menitove JE, Aster RH, Casper JT. et al. T-lymphocyte subpopulations in patients with classic hemophilia treated with cryoprecipitate and lyophilized concentrates. N Engl J Med 1983; 308: 83-86
  • 18 Weintraub P, Ammann AJ, Abrams D. et al Altered T-cell immunity in hemophiliacs receiving frequent factor VIII concentrate. Blood 1982; 6 Suppl (Suppl. 01) 224 a (Abstr)
  • 19 Ledbetter JA, Evans RL, Lipinske M, Cunningham-Rundles C, Good RA, Herzenberg LA. Evolutionary conservation of surface molecules that distinguish T-lymphocytes helper/inducer and T- cytotoxic/suppressor subpopulations in mouse and man. J Exp Med 1981; 153: 310-318
  • 20 Loken MR, Herzenberg LA. Analysis of cell populations with a fluoroscence-activated cell sorter. Ann N Y Acad Sei 1975; 254: 163-171
  • 21 Mayr WR, Müller-Eckhardt G, Krüger M. HLA-DR in chronic idiopathic thrombocytopenic purpura (ITP). Tissue antigens 1981; 18: 56-57
  • 22 Müller-Eckhardt C, Mayr W, Lechner K. et al. HLA-antigens in immunologic thrombocytopenic purpura (ITP). Scand J Haematol 1979; 23: 348-352
  • 23 Vieira J, Frank E, Spira TJ, Landesman SH. Acquired immune deficiency in Haitians. N Engl J Med 1983; 308: 125-129
  • 24 Marx JL. New disease baffles medical community. Science 1982; 217: 618-621
  • 25 Friedmann-Kien AE, Laubenstein LJ, Rubinstein P. et al. Disseminated Kaposi’s sarcoma in homosexual men. Ann Intern Med 1982; 96: 693-700
  • 26 Morris L, Distenfeld A, Amorosi E, Karpatkin S. Autoimmune thrombocytopenic purpura in homosexual men. Ann Intern Med 1982; 96: 714-717
  • 27 Diffuse, undifferentiated non-Hodgkin lymphoma among homosexual males-United States. Morbid Mortal Weekly Rep. 1982 31. 277-279
  • 28 Ratnoff OD, Menitove JE, Aster RH, Ledermann MM. Coincident classic hemophilia and »idiopathic« thrombocytopenic purpura in patients under treatment with concentrates of antihemophilic factor (factor VIII). N Engl J Med 1983; 308: 439
  • 29 Reinherz EL, O’Brien C, Rosenthal P, Schlossmann SF. The cellular basis of viral-induced immunodeficiency: analysis by monoclonal antibodies. J Immunol 1980; 125: 1269-1274